Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC Infusion for GVHD, PGF, or Low Chimerism
NCT00603330Phase 2Recruiting
- Sponsor
- University of Liège
- Start
- Jan 2008
- Primary completion
- Aug 2024
- Modality
- Stem Cell Therapies
- Countries
- 2
01
Overview
A Phase 2 trial of mesenchymal stem cells in graft-versus-host disease (GVHD), poor graft function (PGF), sponsored by University of Liège. Started Jan 2008; status: recruiting.
02
Drugs
mesenchymal stem cells
03
Conditions
graft-versus-host disease (GVHD)poor graft function (PGF)
Beyond the preview
Go deeper on NCT00603330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00603330.